Sunday, 19 November 2017

Pharma/BioPharma News

  • Technology Development Board enters into an agreement with Panacea Biotech

    Pharma/BioPharma |  News | 0 Comment | 16 Nov, 2017

    Technology Development Board which is a part of department of science and technology enters into an agreement with Panacea Biotec Pvt Ltd. for the late stage development including Phase II ...Read more

  • Alembic Pharma acquires Orit Laboratories

    Pharma/BioPharma |  News | 0 Comment | 03 Nov, 2017

    Gujarat-based drugmaker Alembic Pharmaceuticals Ltd has bought US-based generic drug developer Orit Laboratories LLC from Okner Realty LLC in its first cross-border acquisition.The acquisit...Read more

  • India’s generics exports expanding 22% per year

    Pharma/BioPharma |  News | 0 Comment | 24 Oct, 2017

    The India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) provide an update on the country’s generics market as the world’s pharma i...Read more

  • Intas Pharma slashes cancer drug prices

    Pharma/BioPharma |  News | 0 Comment | 06 Oct, 2017

    Intas Pharmaceuticals Ltd has announced that it will cut down the prices of Bevacizumab drug by 60 per cent. The company states that it will bring relief to a large number of cancer patient...Read more

  • Typhoid vaccine by Bharat Biotech shows efficacy

    Pharma/BioPharma |  News | 0 Comment | 03 Oct, 2017

    Vaccine Innovator Bharat Biotech has announced that its next generation typhoid vaccine, Typbar-TCV, has demonstrated its safety and efficacy in a high risk human challenge clinical study c...Read more

  • Hilleman Laboratories receives Indo-Swedish grant for developing - Oral Cholera Vaccine

    Pharma/BioPharma |  News | 0 Comment | 28 Sep, 2017

    Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, received a 6 million krona (737281.80 US Dollar) Indo – Swedish grant for the project ‘Improve...Read more

  • MSD announces entry of Keytruda in India

    Pharma/BioPharma |  News | 0 Comment | 13 Sep, 2017

    US biopharmaceutical giant Merck, Sharpe and Dohme (MSD) has launched its blockbuster cancer drug ‘Keytruda’ (pembrolizumab) in India around a year after it first received appro...Read more

  • Kidney stone drug from Strides Shasun receives USFDA approval

    Pharma/BioPharma |  News | 0 Comment | 12 Sep, 2017

    Strides Shasun Limited has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq Acc...Read more

  • Dr. Reddy's launches antidepressants in the US market

    Pharma/BioPharma |  News | 0 Comment | 06 Sep, 2017

    Dr. Reddy’s Laboratories Ltd. has launched Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 150 mg and 300 mg, a therapeutic equivalent generic version of Wellbutrin XL&nbs...Read more

  • JDRF joins Biocon for global diabetes study

    Pharma/BioPharma |  News | 0 Comment | 06 Sep, 2017

    Asia’s premier biopharmaceuticals company, and JDRF, the leading global organization funding type 1 diabetes (T1D) research and advocacy worldwide, jointly announced a JDRF  part...Read more

  • Dr. Reddy’s launches Cefixime for Oral Suspension

    Pharma/BioPharma |  News | 0 Comment | 28 Aug, 2017

    Dr. Reddy’s Laboratories Ltd. has announced that it has launched Cefixime for Oral Suspension, USP 100 mg/5mL and 200 mg/5mL, a therapeutic equivalent generic version of Suprax (cefix...Read more

  • MDR TB drug by Otsuka reaches India

    Pharma/BioPharma |  News | 0 Comment | 25 Aug, 2017

    Japanese drug maker Otsuka Pharmaceutical has granted US pharmaceutical firm Mylan’s subsidiary an exclusive license to supply to India and South Africa a drug to treat patients with ...Read more

  • Growing pharma sector to boost laboratory, analysis and diagnostics market in India

    Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

    The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and is expected to grow to US$ 100 billion by 2025. The Unio...Read more

  • National Bio Entrepreneurship Competition launched by Y.S. Chowdary

    Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

    The National Bio Entrepreneurship Competition which is a national platform to attract, identify and nurture bio-entrepreneurs with path-breaking ideas for societal impact has been launched ...Read more

  • UBM India announces 4rth edition of PharmaLytica event

    Pharma/BioPharma |  News | 0 Comment | 04 Aug, 2017

    UBM India, organizers of CPhI / P-MEC India, the leading global pharma trade show and conference, announced the 4th edition of PharmaLytica 2017. The two day event will be held at the HITEX...Read more

  • Cipla to explore marketing tie-up with Novartis

    Pharma/BioPharma |  News | 0 Comment | 14 Jul, 2017

    Cipla, India’s third largest drug maker, and Swiss giant Novartis are in early-stage discussions to jointly market asthma drug Xolair, just months after they ended a legal battle over...Read more

  • Takeda collaborates with Biological E

    Pharma/BioPharma |  News | 0 Comment | 27 Jun, 2017

    Japan’s Takeda and Biological E. Ltd. have agreed to collaborate on affordable combination vaccines. Takeda will transfer its measles and acellular pertussis vaccine bulk production ...Read more

  • Leo Pharma invests into Novopyxis

    Pharma/BioPharma |  News | 0 Comment | 22 Jun, 2017

    Leo Pharma announced an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical t...Read more

Survey Box

Are Indian drug firms still cautious of executing big mergers & acquistions?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls